Target intelligence / Profile preview

Multiple immune and non-immune cell populations via cell-cell contact and secretome

Molecular classification
Other
01

Overview

The phrase 'Multiple immune and non-immune cell populations via cell-cell contact and secretome' does not identify a specific molecular target but rather describes a complex biological system of cellular communication. It refers to the multifaceted interactions between various cell types, such as lymphocytes, macrophages, fibroblasts, and endothelial cells, which are mediated through direct physical contact and the release of soluble factors known as the secretome (Alberts B, et al. Molecular Biology of the Cell, 2014). Cell-cell contact involves membrane-bound ligand-receptor interactions that trigger intracellular signaling, while the secretome consists of cytokines, chemokines, and growth factors that act in a paracrine or autocrine fashion (Makridakis M, et al. J Proteomics, 2013). This terminology is often used to characterize the broad, pleiotropic effects of cell-based therapies, such as mesenchymal stem cells, which modulate the immune microenvironment through these combined mechanisms (Vizoso FJ, et al. Int J Mol Sci, 2017). Because it encompasses a wide array of molecules and cellular processes, it lacks the specificity required to be classified as a discrete therapeutic target in drug development. Consequently, it represents a description of a biological phenomenon or a drug's mechanism of action rather than a single druggable protein or receptor.

02

Mechanism of action

Not applicable as this is a description of a biological process rather than a molecular target.

03

Biological functions

Cell-cell signalingImmune responseParacrine signalingTissue homeostasis
04

Disease associations

InflammationAutoimmune diseaseCancerGraft versus host disease
05

Safety considerations

Lack of molecular specificityPotential for systemic off-target effectsComplexity in therapeutic standardization

Beyond the preview

Go deeper on Multiple immune and non-immune cell populations via cell-cell contact and secretome.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Multiple immune and non-immune cell populations via cell-cell contact and secretome.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call